Literature DB >> 1352123

Crescentic glomerulonephritis in children.

H M Jardim1, J Leake, R A Risdon, T M Barratt, M J Dillon.   

Abstract

Data on patients with crescentic glomerulonephritis (greater than 50% glomeruli with crescents), referred to the Hospital for Sick Children during the past 13 years, were reviewed. Thirty patients (13 male, 17 female) aged 3.7-15.7 years (mean 9.5) were evaluated. Initial clinical features included: oedema (24/30), hypertension (19/30), gross haematuria (15/30), oliguria (15/30) and a decreased glomerular filtration rate (GFR less than 30 ml/min per 1.73 m2) (22/30). Henoch-Schönlein purpura was present in 9 patients, microscopic polyarteritis in 3, polyarteritis nodosa in 1, Wegener's granulomatosis in 1, systemic lupus erythematosus in 1, post-streptococcal glomerulonephritis in 2, mesangiocapillary glomerulonephritis in 7, anti-glomerular basement membrane glomerulonephritis in 2, and 4 were idiopathic. In 10 patients 50%-79% of glomeruli were affected by crescentic changes (group 1) and in the remaining 20, 80% or more (group 2). The crescents were cellular, fibrocellular or fibrous, and the degree of sclerosis was assessed. Patients in both groups were treated with plasma exchange, corticosteroids, anticoagulants, cyclophosphamide and azathioprine in different combinations. On follow-up, 3 patients were dead, 1 was lost to follow-up, 12 were on dialysis/transplant programmes, 4 had a GFR of less than 30 and 10 a GFR of more than 30 ml/min per 1.73 m2. In our experience, 50% progressed to end-stage renal failure. The interval between disease onset and start of treatment was a prognostic factor for outcome. Fibrous crescents were associated with a worse outcome than fibrocellular crescents (P less than 0.05). Outcome was not, however, related to the percentage of glomeruli affected (P greater than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352123     DOI: 10.1007/bf00878354

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases.

Authors:  R Habib; C Kleinknecht; M C Gubler; M Levy
Journal:  Clin Nephrol       Date:  1973 Jul-Aug       Impact factor: 0.975

2.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

3.  Antineutrophil cytoplasm antibody in crescentic glomerulonephritis.

Authors:  M D Walters; C O Savage; M J Dillon; C M Lockwood; T M Barratt
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

4.  Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis.

Authors:  W K Bolton; B C Sturgill
Journal:  Am J Nephrol       Date:  1989       Impact factor: 3.754

5.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

6.  Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.

Authors:  C M Lockwood; A J Rees; T A Pearson; D J Evans; D K Peters; C B Wilson
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

7.  Rapidly progressive glomerulonephritis with extensive glomerular crescent formation.

Authors:  G H Neild; J S Cameron; C S Ogg; D R Turner; D G Williams; C B Brown; C Chantler; J Hicks
Journal:  Q J Med       Date:  1983

Review 8.  Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy.

Authors:  W G Couser
Journal:  Am J Kidney Dis       Date:  1988-06       Impact factor: 8.860

9.  A clinico-pathologic study of crescentic glomerulonephritis in 50 children. A report of the Southwest Pediatric Nephrology Study Group.

Authors: 
Journal:  Kidney Int       Date:  1985-02       Impact factor: 10.612

10.  Poststreptococcal crescenteric glomerulonephritis in children: comparison of quintuple therapy versus supportive care.

Authors:  S Roy; W M Murphy; B S Arant
Journal:  J Pediatr       Date:  1981-03       Impact factor: 4.406

View more
  25 in total

Review 1.  Henoch-Schönlein purpura.

Authors:  E J Tizard
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  The use of immunosuppressive and cytotoxic drugs in non-malignant disease.

Authors:  P A Brogan; M J Dillon
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

3.  Favorable outcome in a case of Mycoplasma pneumoniae-associated crescentic glomerulonephritis.

Authors:  Anne-Laure Adra; Marie-Gabrielle Vigue; Fabienne Dalla Vale; Lydia Ichay; Pierre Raynaud; Aude Mariani; Denis Morin
Journal:  Pediatr Nephrol       Date:  2010-03-25       Impact factor: 3.714

4.  Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.

Authors:  Mazdak A Khalighi; Shihtien Wang; Kammi J Henriksen; Margret Bock; Mahima Keswani; Anthony Chang; Shane M Meehan
Journal:  Pediatr Nephrol       Date:  2015-02-12       Impact factor: 3.714

Review 5.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

6.  Acute postinfectious crescentic glomerulonephritis: clinicopathologic presentation and risk factors.

Authors:  Amr A El-Husseini; Hussein A Sheashaa; Alaa A Sabry; Fatma E Moustafa; Mohamed A Sobh
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

7.  Childhood vasculitis and plasma exchange.

Authors:  Elizabeth Wright; Michael J Dillon; Kjell Tullus
Journal:  Eur J Pediatr       Date:  2006-08-17       Impact factor: 3.183

8.  Anti-neutrophil cytoplasmic auto-antibodies-associated vasculitis with pulmonary and renal involvement.

Authors:  G Pintos-Morell; A Roca-Comas; M A Naranjo; C Tural; E Abad; G Javier; J Prats
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

9.  Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children.

Authors:  William Wong; Maxwell Clarke Morris; Jonathan Zwi
Journal:  Pediatr Nephrol       Date:  2008-12-19       Impact factor: 3.714

Review 10.  Small vessel vasculitis.

Authors:  Paul Brogan; Despina Eleftheriou; Michael Dillon
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.